Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI

European Radiology

Volumn 22, Issue 12, 2012, Pages 2641-2647

  King, Valencia ^a   Gu, Yajia ^b,c   Kaplan, Jennifer B ^a   Brooks, Jennifer D ^a   Pike, Malcolm C ^a   Morris, Elizabeth A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Breast; Enhancement; Fibroglandular tissue; Menopause; MRI

Indexed keywords

ADULT; AGE; ARTICLE; BACKGROUND PARENCHYMAL ENHANCEMENT; BREAST; BREAST FIBROGLANDULAR TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDIES; RISK FACTORS; SUBTRACTION TECHNIQUE;

EID: 84870359259     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2553-8     Document Type: Article

References (15)

1. Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203: 137-144
2. Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 45: 863-880
3. Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203: 145-149
4. Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 196: 218-224
5. King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260: 50-60
6. Hattangadi J, Park C, Rembert J et al (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol 190: 1630-1636
7. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging - initial observations. Radiology 235: 36-41
8. Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232-238
9. Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 17: 1696-1701
10. Oksa S, Parkkola R, Luukkaala T, Maenpaa J (2009) Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 50: 984-989
11. Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259: 65-71
12. American College of Radiology BI-RADS Committee (2003) Breast Imaging Reporting and Data System, 4th edn. American College of Radiology, Reston, Virginia
13. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174
14. Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM (2011) Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 21: 1374-1382
15. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11: 1048-1053